Navigation Links
American Scientific Resources To Be Exclusive Seller of World's Only FDA Approved Home Needle Destruction Device
Date:8/19/2009

WESTON, Fla., Aug. 19 /PRNewswire-FirstCall/ -- In keeping with its mission to provide unique products that greatly benefit the wellbeing of families, American Scientific Resources (the Company) (Pink Sheets: ASFX), today announced it has obtained from Safeguard Medical Technologies, LLC exclusive worldwide rights to sell and market home Needle Destruction Devices (NDD) known as the Disintegrator(TM) and the Disintegrator Plus(TM).

All current and future sales and contracts worldwide have been granted to the Company.

Currently the only NDD approved for home use by the U.S. Food and Drug Administration, the Disintegrator enables patients who need to give themselves injections to properly and safely dispose of their used needles at home. The Disintegrator utilizes a unique plasma arc to melt the needle at a temperature of over 3000 degrees Fahrenheit (ensuring the elimination of any pathogens), reducing it to a small bb-shaped ball. It uses patented technology that gives it distinct advantages over similar devices.

"We are quite pleased to have acquired exclusivity on such an innovative product as the Disintegrator," stated Dr. Christopher F. Tirotta, CEO of American Scientific Resources, Inc. "Potential worldwide sales look most encouraging."

The Disintegrator has enormous potential to become a world leader in its market. For example, multiple sclerosis, diabetes and HIV Patients may require daily injections; this device will ensure that their syringes do not end up harming anyone from family members to waste haulers.

A congressional bill (S, 1312) is pending which would amend Title XVIII of the Social Security Act to provide for coverage of supplies associated with the injection of insulin, of containment, removal, decontamination, and dis
'/>"/>

SOURCE American Scientific Resources, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  (PSHR) Pacific ... naturally based products across a broad range of ... has retained investor relations firm, BlueWater Advisory Group, ... return to trading process, and to direct the ... initiation. Matthew Mills ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 With bed bugs' ... said that although bed bugs need to be eliminated, one ... not compromise a person's health. And so to help bed ... to get rid of bed bugs without using ... bed bug spray it called Bed Bug Bully. , According ...
(Date:5/20/2013)... , May 20, 2013   Flexion Therapeutics ... Frederick W. Driscoll to its management team ... 30 years of financial management experience with biotechnology and ... Mr. Driscoll was chief financial officer for Novavax (NASDAQ: ... that secured more than $250 million through a combination ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Researchers from the ... the connection between lower back pain, and the acne causing ... in the system the bacteria seek out oxygen deprived location ... in the spinal column, P.acnes has the ability to live ... , Fernando Perez, a spokesman for “ The best acne ...
Breaking Biology Technology:Pacific Shore Holdings Retains Investor Relations Firm 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2
... 20 Kosan Biosciences,Incorporated (Nasdaq: KOSN ) ... as Senior Vice President and Chief Medical Officer. ... development and registration of cancer,therapeutics and has had ... and clinical pharmacologist, most notably at Novartis. Dr. ...
... are making a considerable impact on many aspects ... Reaching for the human frontier, robotics is also ... emerging domains. Interacting, exploring, and working with humans, ... peoples lives. The prospect of practical robots among ...
... 19 Mass spectrometry, driven by,a broad range of ... an increasing number of applications in the clinic, according,to ... Engineering and Biotechnology,News (GEN) ( http://www.genengnews.com ). Mass spec ... to a growing focus on screening patients through,the identification ...
Cached Biology Technology:Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer 2Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer 3Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer 4Robots moving closer to humans 2Genetic Engineering and Biotechnology News (GEN) Reports on Mass Spec in Drug Discovery 2
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
(Date:5/20/2013)... popularly known as the lungs of the planet, inhales carbon ... the air to grow parts that eventually fall to the ... plentiful rainfall. , Until recently people believed much of ... ended up deep in the ocean. University of Washington research ... carbon dioxide though left open the question of how ...
Breaking Biology News(10 mins):Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... TGen Drug Development (TD2) and the Institut ... will enable both to maximize their worldwide contributions ... The partnership between TD2, a Scottsdale subsidiary of ... Marseille, France-based IPC,s comprehensive cancer center will enable ...
... University Medical Center in New York have confirmed that ... not a descendant of healthy humans dwarfed by disease. ... specimen, researchers determined the "hobbit" to be a distinct species ... Details of the study appear in the December issue of ...
... a step toward using human saliva to tell whether those ... are normal or red flags for disease, scientists are describing ... age. The discovery could lead to a simple, noninvasive test ... they suggest in a report in ACS, Journal of ...
Cached Biology News:TGen Drug Development establishes European footprint 2'Hobbits' are a new human species -- according to the statistical analysis of fossils 2
Glutamate Receptor 5/1a...
Ly-49C and Ly-49I Biotin Anti-Mouse clone 5E6, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Mouse monoclonal [M7-PB-E9] to pan alpha Sodium Potassium ATPase ( Abpromise for all tested applications)....
Gentamicin sulfate, 5g...
Biology Products: